Med Life S.A., a private healthcare provider, offers healthcare services in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures. Its Corporate business line offers health prevention packages to corporate clients, which cover regular check-ups and access to diagnostic services. The company's Clinics business line provides services through hyper clinics for clinical examinations and imaging services, as well as clinics that offer a range of treatments from general practitioner services to specialists, as well as day inpatient services. Its Laboratories business line offers biochemistry, pathological anatomy, molecular biology and genetics, haematology, immunology, microbiology, and toxicology services. The company's Hospitals business line provides medical care, accommodation, meals, use of equipment, pharmacy stock, and nursing services. Its Stomatology business line offers a range of services comprising medical examinations, surgery, implants, or orthodontic services. The company's Pharmacies business line offers prescription and non-prescription pharmaceutical products, and laboratory prepared products, as well as other related medical products. Its Pharmaceutical distribution business line engages in the storage, handling, and transportation of pharmaceutical products from manufacturers to end users. The company's Wellness business line operates a chain of Sweat gyms that offer consultations, investigations and surgical treatments, wellness, nutrition, and sports services. The company is also involved in the development of building projects, dental healthcare, and insurance brokerage businesses; rental activities; and operates a medical platform. Med Life S.A. was incorporated in 1996 and is headquartered in Bucharest, Romania.
Metrics to compare | ROM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipROMPeersSector | |
---|---|---|---|---|
P/E Ratio | 172.8x | 1.0x | −0.6x | |
PEG Ratio | - | 0.01 | 0.00 | |
Price/Book | 7.2x | 0.9x | 2.6x | |
Price / LTM Sales | 1.3x | 0.7x | 3.1x | |
Upside (Analyst Target) | −5.7% | 19.7% | 55.8% | |
Fair Value Upside | Unlock | 18.8% | 7.3% | Unlock |